Targeted pill shows promise against hard-to-treat thyroid and other cancers
NCT ID NCT04280081
First seen Apr 25, 2026 · Last updated Apr 25, 2026
Summary
This study tests an oral drug called selpercatinib in 77 people in China who have advanced solid tumors or medullary thyroid cancer with a specific RET gene change. The main goal is to see if the drug can shrink tumors and how safe it is. Participants take the drug daily and are monitored for response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130000, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Shanghai Chest Hospital
Shanghai, Shanghai/China, 200030, China
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200120, China
-
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, 510515, China
-
The First Affiated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
-
The First Affiliated Hospital, Zhejiang University
Hangzhou, Zhejiang, 310003, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300060, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 310014, China
Conditions
Explore the condition pages connected to this study.